Threshold Pharmaceuticals Inc. (THLD): Today's Featured Drugs Winner
(
) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day down 1.3%. By the end of trading, Threshold Pharmaceuticals rose 26 cents (3.8%) to $7.20 on average volume. Throughout the day, 2.8 million shares of Threshold Pharmaceuticals exchanged hands as compared to its average daily volume of 2.5 million shares. The stock ranged in a price between $6.68-$7.32 after having opened the day at $6.88 as compared to the previous trading day's close of $6.94. Other companies within the Drugs industry that increased today were:
(
), up 21.9%,
(
), up 15.7%,
(
), up 11.7%, and
(
), up 8.9%.
Threshold Pharmaceuticals, Inc., a development stage company, focuses on the discovery and development of drugs for the microenvironment of solid tumors and the bone marrows of hematologic malignancies as novel treatments for patients living with cancer. Threshold Pharmaceuticals has a market cap of $370.6 million and is part of the
sector. Shares are up 468.9% year to date as of the close of trading on Tuesday. Currently there are three analysts that rate Threshold Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.
TheStreet Ratings rates Threshold Pharmaceuticals as a
. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income.
- You can view the full Threshold Ratings Report.
On the negative front,
(
), down 13.2%,
(
), down 11.8%,
(
), down 11.5%, and
(
), down 10.3%, were all losers within the drugs industry with
(
) being today's drugs industry loser.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider
(
) while those bearish on the drugs industry could consider
ProShares UltraShort Nasdaq Biotech
(
).
- Find other investment ideas from our top rated ETFs lists.
null
